US20010012948A1 - Insertion tool for transmyocardial implant - Google Patents
Insertion tool for transmyocardial implant Download PDFInfo
- Publication number
- US20010012948A1 US20010012948A1 US09/793,318 US79331801A US2001012948A1 US 20010012948 A1 US20010012948 A1 US 20010012948A1 US 79331801 A US79331801 A US 79331801A US 2001012948 A1 US2001012948 A1 US 2001012948A1
- Authority
- US
- United States
- Prior art keywords
- sheath
- vessel
- implant
- lumen
- dilator
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2493—Transmyocardial revascularisation [TMR] devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3415—Trocars; Puncturing needles for introducing tubes or catheters, e.g. gastrostomy tubes, drain catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
- A61B2017/00247—Making holes in the wall of the heart, e.g. laser Myocardial revascularization
- A61B2017/00252—Making holes in the wall of the heart, e.g. laser Myocardial revascularization for by-pass connections, i.e. connections from heart chamber to blood vessel or from blood vessel to blood vessel
Definitions
- This invention pertains to an implant for passing blood flow directly between a chamber of the heart and a coronary vessel. More particularly, this invention pertains to an insertion tool to facilitate insertion of such an implant into the coronary vessel.
- U.S. Pat. No. 5,755,682 dated May 26, 1998 and PCT Application No. PCT/US97/13980 International Publication No. WO 98/06356 based U.S. Pat. application Ser. No. 08/882,397 filed Jun. 25, 1997) teach an implant for defining a blood flow conduit directly from a chamber of the heart to a lumen of a coronary vessel.
- An embodiment disclosed in the aforementioned patent and applications teaches an L-shaped implant in the form of a rigid conduit. The conduit has one leg sized to be received within a lumen of a coronary artery and a second leg sized to pass through the myocardium and extend into the left ventricle of the heart.
- the conduit is rigid and remains open for blood flow to pass through the conduit during both systole and diastole.
- the conduit penetrates into the left ventricle in order to prevent tissue growth and occlusions over an opening of the conduit.
- Implants such as those shown in the aforementioned applications include a portion to be placed within a coronary vessel and a portion to be placed within the myocardium.
- the vessel When placing a portion of the implant in the coronary vessel, the vessel is axially incised a length sufficient to insert the implant.
- Such an incision results in a contraction of the coronary vessel to a size substantially smaller than the implant. Therefore, it is difficult to insert the implant into the lumen of the coronary vessel.
- Such vessels are elastic and can be urged to an expanded shape sufficient to fit over the implant.
- due to the small size of the vessel restricted space for manipulating surgical tools, and the importance of avoiding damage to the coronary vessel, such a manipulation of the vessel is difficult.
- an insertion tool for facilitating insertion of a vessel end of a transmyocardial implant into a coronary vessel.
- the transmyocardial implant has a hollow conduit for establishing a blood flow path through a myocardium between a heart chamber and a lumen of a coronary vasculature residing on an exterior of said wall.
- the vessel end has an external geometry for the vessel end to be received within the lumen.
- the vessel end has a generally tubular external geometry and an axial opening at a leading end.
- the coronary vessel has a constricted size and is expandable to a larger expanded size.
- the insertion tool includes a sheath having an external dimension sized for the sheath to be received within the lumen of the expanded size of the coronary vessel.
- a dilator is removably inserted through the sheath.
- a leading end of the dilator is sized to be received within the lumen of the constricted size of the coronary vessel.
- the dilator is removed from the sheath after placement of the dilator and sheath in the vessel.
- the implant is then placed in the sheath.
- the sheath is retracted from the vessel without disrupting the coronary vessel.
- FIG. 1 is a side elevation view of an implant for use with the present invention
- FIG. 2 is the view of FIG. 1 showing the implant of FIG. 1 and showing, in cross section, a tissue growth-inducing material secured to an exterior of the conduit and showing the implant positioned within the myocardium and lumen of a coronary vessel;
- FIG. 3 is a side-elevation view of an insertion tool according to the present invention.
- FIG. 4 is the view of FIG. 3 and showing dilator and sheath components separated
- FIG. 5 is an enlarged view of the dilator inserted within the sheath and showing the sheath in cross-section;
- FIG. 6 is a rear, bottom and side perspective view of the sheath.
- a conduit 10 is shown in the form of an L-shaped rigid tube.
- the conduit 10 may be formed of titanium or other rigid biocompatible material such as pyrolytic carbon or may be titanium coated with pyrolytic carbon.
- the material of the conduit 10 is preferably a rigid material in order to withstand contraction forces of the myocardium.
- the tube will have an outside diameter Do of about 3.0-2.0 millimeters and an internal diameter D I of about 2.5-1.5 millimeters to provide a wall thickness of about 0.5 millimeters.
- the tube 10 has a first portion (or vessel end) 12 sized to be received within the lumen of a coronary vessel such as the lumen 100 of a coronary artery 102 illustrated in FIG. 2.
- the conduit 10 has a second portion (or myocardium end) 14 extending at a right angle to the axis of portion 12 .
- the second portion 14 is sized to extend from the coronary artery 102 directly through the myocardium 104 and protrude into the left ventricle 106 of a patient's heart.
- the second portion 14 is sized to have a length sufficient for the portion 14 to protrude into the left ventricle 106 .
- the vessel end 12 has a first opening 16 and the myocardium end 14 has a second opening 18 in communication with an interior 20 of the implant 10 . Therefore, blood can freely flow through the implant 10 between the left ventricle 106 and the lumen 100 of the coronary artery 102 .
- a leading end 22 of the vessel end 12 is tubular.
- a sleeve 52 includes a first end 54 with sutures 56 disposed around end 54 to retain end 54 within the groove 24 .
- the material at the first end 54 is folded over the sutures 56 and stitched by stitching 58 to secure the first end 54 in the groove 24 and to immobilize the first end 54 relative to the tube 10 .
- a second end 60 of the sleeve 52 is retained by sutures 62 in the groove 26 and threading 64 secures the material of the sleeve 52 over the sutures 62 .
- the stitching 58 , 64 is shown exposed on an exterior of the sleeve 52 .
- the sleeve 52 can be formed inverted so that the stitching 58 , 64 is not exposed.
- the sleeve 52 is formed of a fabric having biocompatible fibers defining interstitial spaces to receive tissue growth.
- a fabric is polyethylene terephthalate (such as polyester fabric sold by DuPont Company under the trademark Dacron).
- a fabric permits rapid tissue integration into the fabric to anchor the fabric and, hence, the tube 10 to the patient's tissue.
- the first portion 12 is secured in place by means of a reduced-diameter groove 13 formed adjacent the leading end 22 . With the reduced-diameter groove 13 , a surgeon can place sutures 70 surrounding the coronary artery 102 to secure the coronary artery 102 immobilized at the groove 13 .
- an incision 83 is made on an upper surface of the artery 102 distal to a coronary obstruction 85 .
- the portion of the artery 82 proximal to the implant 10 is closed by sutures 88 .
- the process of incising the artery 102 results in contraction of the artery 102 to a reduced diameter.
- an artery 102 such as the left anterior descending artery (LAD) may contract down to 0.5 mm. This is smaller than the diameter of the leading end 22 of the implant 10 .
- the artery 102 is elastic and may be expanded to an enlarged expanded diameter (e.g., 2-5 mm). However, it is difficult to manipulate tools to expand the artery 102 due to the small space available to work.
- the insertion tool 200 includes a sheath 201 and a mating dilator 203 .
- the sheath 201 includes a straight handle 205 .
- a sheath funnel 207 is secured to an end of the handle with a funnel axis X-X perpendicular to the handle 205 .
- a bottom side 209 of the funnel 207 is cut-away.
- the funnel 207 tapers from a large diameter trailing end 211 to a narrow leading end 213 .
- the inner diameter of the trailing end 211 is larger than the outside diameter of the implant's leading end 22 .
- the inside diameter of the leading end 213 is only slightly larger than the outside diameter of the implant's leading end 22 .
- the inside diameter of the funnel training end 211 is 5.5 mm and the inside diameter of the of the funnel leading end 213 is 2.5 mm.
- a hollow, cylindrical sheath body 215 is secured to the leading end 213 of the funnel 207 .
- the cylindrical axis of the sheath body 215 is co-linear with axis X-X.
- the sheath body will have a uniform inside diameter of 2.5 mm and, except as will be described, an outside diameter of 2.7 mm.
- the outside diameter of the sheath body 215 is tapered down to 2.5 mm.
- the leading end 215 is rounded so as not to present a sharp edge to a coronary vessel upon insertion.
- the sheath body 215 is scored by a score line 219 running axially the entire length of the sheath body 215 .
- the score line 219 may be a partial cut through the material of the sheath body 215 to weaken the material such that upon application of force, as will be described, the sheath body 215 will tear along the score line 219 .
- the score line 219 can be a lengthwise through-cut (as shown in the drawings) or can be a series of holes to define a perforation line.
- the dilator 203 has cylindrical body portion 202 and a conical, tapered portion 204 .
- the tapered portion 204 extends axially from the body portion 202 .
- the opposite end of the body portion 202 is provided with a handle 206 to permit grasping of the dilator 206 .
- the handle 206 projects at a 90° angle to the is of the body portion 202 .
- the dilator body portion 202 is sized with an outside diameter slightly larger than the inside diameter of the sheath body 215 .
- the body portion has an outside diameter of 2 . 5 mm.
- the tapered portion tapers to a rounded leading end 208 which, in the example given, has a diameter of 1.0 mm.
- the dilator 203 is secured to the sheath 201 by the dilator handle 206 being releasably secured in clips 219 on the sheath handle 205 .
- the dilator body portion 202 is slidably received within the sheath body 215 and the dilator tapered portion 204 protrudes beyond the sheath leading end 217 .
- the leading end 208 of the tapered portion 204 is sized to have a diameter sufficiently small for the leading end 208 to slip into the lumen 100 of the contracted size artery 102 . Further advancement of the dilator and sheath dilates the vessel. A small portion of the full diameter dilator body 202 extends beyond the sheath leading end 217 so the vessel is fully dilated before the sheath body 215 is urged into the vessel.
- the contracted size artery 102 can easily slip over the leading end 208 of the dilator 203 . Both the dilator and sheath may be lubricious to ease insertion into the vessel. As a result of such insertion, the artery 102 expands to an expanded size surrounding the sheath body 215 .
- the dilator 203 can be removed.
- the implant leading end 22 is then placed in the sheath body 215 .
- the implant leading end 22 is inserted into the guide funnel 207 .
- the guide funnel 207 directs the implant leading end 22 into the cylindrical sheath body 215 . So inserted, the leading end 22 of the implant 10 is inserted into the artery 102 and the sheath body 215 is positioned between the implant 10 and the artery 102 protecting the artery 102 from trauma.
- the sheath 201 can be removed.
- the physician simply pulls on handle 205 . This imparts a force which splits the score line 219 .
- the surgeon can pull the sheath body 215 rearwardly out of the vessel 102 .
- the flexible material of the sheath body 215 spreads apart at the bend of the implant 10 to pass the split sheath body 215 over the bend so that the sheath body 215 can be removed without disrupting the position of the artery 102 over the implant's leading end 22 .
- any frictional force between the artery 102 and the sheath body 215 will tend to further urge the artery 102 over the leading end 22 . Therefore, the artery 102 remains over the leading end 22 of the implant 10 and surrounding groove 13 so the artery 102 can be fixed to the implant 10 with sutures 70 (FIG. 2) surrounding groove 13 .
Abstract
Description
- 1. Field of the Invention
- This invention pertains to an implant for passing blood flow directly between a chamber of the heart and a coronary vessel. More particularly, this invention pertains to an insertion tool to facilitate insertion of such an implant into the coronary vessel.
- 2. Description of the Prior Art
- U.S. Pat. No. 5,755,682 dated May 26, 1998 and PCT Application No. PCT/US97/13980 (International Publication No. WO 98/06356 based U.S. Pat. application Ser. No. 08/882,397 filed Jun.25, 1997) teach an implant for defining a blood flow conduit directly from a chamber of the heart to a lumen of a coronary vessel. An embodiment disclosed in the aforementioned patent and applications teaches an L-shaped implant in the form of a rigid conduit. The conduit has one leg sized to be received within a lumen of a coronary artery and a second leg sized to pass through the myocardium and extend into the left ventricle of the heart. As disclosed in the above-referenced patent and applications, the conduit is rigid and remains open for blood flow to pass through the conduit during both systole and diastole. The conduit penetrates into the left ventricle in order to prevent tissue growth and occlusions over an opening of the conduit.
- Commonly assigned and co-pending U.S. Pat. application Ser. No. 08/944,313 filed Oct. 6, 1997, entitled “Transmyocardial Implant” teaches an implant such as that shown in the aforementioned '682 patent with an enhanced fixation structure. The enhanced fixation structure includes a fabric surrounding at least a portion of the conduit to facilitate tissue growth on the exterior of the implant.
- Implants such as those shown in the aforementioned applications include a portion to be placed within a coronary vessel and a portion to be placed within the myocardium. When placing a portion of the implant in the coronary vessel, the vessel is axially incised a length sufficient to insert the implant. Such an incision results in a contraction of the coronary vessel to a size substantially smaller than the implant. Therefore, it is difficult to insert the implant into the lumen of the coronary vessel. Such vessels are elastic and can be urged to an expanded shape sufficient to fit over the implant. However, due to the small size of the vessel, restricted space for manipulating surgical tools, and the importance of avoiding damage to the coronary vessel, such a manipulation of the vessel is difficult.
- According to a preferred embodiment of the present invention, an insertion tool is disclosed for facilitating insertion of a vessel end of a transmyocardial implant into a coronary vessel. The transmyocardial implant has a hollow conduit for establishing a blood flow path through a myocardium between a heart chamber and a lumen of a coronary vasculature residing on an exterior of said wall. The vessel end has an external geometry for the vessel end to be received within the lumen. The vessel end has a generally tubular external geometry and an axial opening at a leading end. The coronary vessel has a constricted size and is expandable to a larger expanded size. The insertion tool includes a sheath having an external dimension sized for the sheath to be received within the lumen of the expanded size of the coronary vessel. A dilator is removably inserted through the sheath. A leading end of the dilator is sized to be received within the lumen of the constricted size of the coronary vessel. The dilator is removed from the sheath after placement of the dilator and sheath in the vessel. The implant is then placed in the sheath. The sheath is retracted from the vessel without disrupting the coronary vessel.
- FIG. 1 is a side elevation view of an implant for use with the present invention;
- FIG. 2 is the view of FIG. 1 showing the implant of FIG. 1 and showing, in cross section, a tissue growth-inducing material secured to an exterior of the conduit and showing the implant positioned within the myocardium and lumen of a coronary vessel;
- FIG. 3 is a side-elevation view of an insertion tool according to the present invention;
- FIG. 4 is the view of FIG. 3 and showing dilator and sheath components separated;
- FIG. 5 is an enlarged view of the dilator inserted within the sheath and showing the sheath in cross-section; and
- FIG. 6 is a rear, bottom and side perspective view of the sheath.
- With initial reference to FIG. 1, a
conduit 10 is shown in the form of an L-shaped rigid tube. Theconduit 10 may be formed of titanium or other rigid biocompatible material such as pyrolytic carbon or may be titanium coated with pyrolytic carbon. The material of theconduit 10 is preferably a rigid material in order to withstand contraction forces of the myocardium. By way of example, the tube will have an outside diameter Do of about 3.0-2.0 millimeters and an internal diameter DI of about 2.5-1.5 millimeters to provide a wall thickness of about 0.5 millimeters. - The
tube 10 has a first portion (or vessel end) 12 sized to be received within the lumen of a coronary vessel such as thelumen 100 of acoronary artery 102 illustrated in FIG. 2. Theconduit 10 has a second portion (or myocardium end) 14 extending at a right angle to the axis ofportion 12. Thesecond portion 14 is sized to extend from thecoronary artery 102 directly through themyocardium 104 and protrude into theleft ventricle 106 of a patient's heart. Thesecond portion 14 is sized to have a length sufficient for theportion 14 to protrude into theleft ventricle 106. - The
vessel end 12 has a first opening 16 and themyocardium end 14 has asecond opening 18 in communication with aninterior 20 of theimplant 10. Therefore, blood can freely flow through theimplant 10 between theleft ventricle 106 and thelumen 100 of thecoronary artery 102. A leadingend 22 of thevessel end 12 is tubular. - As illustrated in FIGS. I and2,
grooves myocardium end 14. Asleeve 52 includes afirst end 54 with sutures 56 disposed aroundend 54 to retainend 54 within thegroove 24. The material at thefirst end 54 is folded over the sutures 56 and stitched by stitching 58 to secure thefirst end 54 in thegroove 24 and to immobilize thefirst end 54 relative to thetube 10. Similarly, asecond end 60 of thesleeve 52 is retained bysutures 62 in thegroove 26 and threading 64 secures the material of thesleeve 52 over thesutures 62. In the figures, thestitching sleeve 52. Alternatively, thesleeve 52 can be formed inverted so that thestitching - Preferably, the
sleeve 52 is formed of a fabric having biocompatible fibers defining interstitial spaces to receive tissue growth. An example of such a fabric is polyethylene terephthalate (such as polyester fabric sold by DuPont Company under the trademark Dacron). Such a fabric permits rapid tissue integration into the fabric to anchor the fabric and, hence, thetube 10 to the patient's tissue. Additionally, thefirst portion 12 is secured in place by means of a reduced-diameter groove 13 formed adjacent the leadingend 22. With the reduced-diameter groove 13, a surgeon can placesutures 70 surrounding thecoronary artery 102 to secure thecoronary artery 102 immobilized at thegroove 13. - The foregoing description with reference to FIGS. 1 and 2 is provided for illustration and is more thoroughly described in the aforementioned U.S. Pat. application Ser. No. 08/944,313 entitled “Transmyocardial Implant”.
- In one method of placing the
vessel end 12 into theartery 102, anincision 83 is made on an upper surface of theartery 102 distal to acoronary obstruction 85. The portion of the artery 82 proximal to theimplant 10 is closed bysutures 88. - The process of incising the
artery 102 results in contraction of theartery 102 to a reduced diameter. For example, anartery 102 such as the left anterior descending artery (LAD) may contract down to 0.5 mm. This is smaller than the diameter of theleading end 22 of theimplant 10. Theartery 102 is elastic and may be expanded to an enlarged expanded diameter (e.g., 2-5 mm). However, it is difficult to manipulate tools to expand theartery 102 due to the small space available to work. - To facilitate placement of the
implant 10 within thevessel 102, anovel insertion tool 200 is disclosed. Theinsertion tool 200 includes asheath 201 and amating dilator 203. - The
sheath 201 includes astraight handle 205. Asheath funnel 207 is secured to an end of the handle with a funnel axis X-X perpendicular to thehandle 205. Abottom side 209 of thefunnel 207 is cut-away. Thefunnel 207 tapers from a largediameter trailing end 211 to a narrowleading end 213. The inner diameter of the trailingend 211 is larger than the outside diameter of the implant's leadingend 22. The inside diameter of theleading end 213 is only slightly larger than the outside diameter of the implant's leadingend 22. By way of non-limiting example, for animplant 10 having an outside diameter Do of 2.5 mm, the inside diameter of thefunnel training end 211 is 5.5 mm and the inside diameter of the of thefunnel leading end 213 is 2.5 mm. - A hollow,
cylindrical sheath body 215 is secured to theleading end 213 of thefunnel 207. The cylindrical axis of thesheath body 215 is co-linear with axis X-X. In the foregoing example, the sheath body will have a uniform inside diameter of 2.5 mm and, except as will be described, an outside diameter of 2.7 mm. At itsleading end 217, the outside diameter of thesheath body 215 is tapered down to 2.5 mm. Preferably, theleading end 215 is rounded so as not to present a sharp edge to a coronary vessel upon insertion. - On a side of the
sheath body 215opposite handle 205, thesheath body 215 is scored by ascore line 219 running axially the entire length of thesheath body 215. Thescore line 219 may be a partial cut through the material of thesheath body 215 to weaken the material such that upon application of force, as will be described, thesheath body 215 will tear along thescore line 219. Alternatively, thescore line 219 can be a lengthwise through-cut (as shown in the drawings) or can be a series of holes to define a perforation line. - The
dilator 203 hascylindrical body portion 202 and a conical, taperedportion 204. The taperedportion 204 extends axially from thebody portion 202. The opposite end of thebody portion 202 is provided with ahandle 206 to permit grasping of thedilator 206. Thehandle 206 projects at a 90° angle to the is of thebody portion 202. - The
dilator body portion 202 is sized with an outside diameter slightly larger than the inside diameter of thesheath body 215. In the example given, the body portion has an outside diameter of 2.5 mm. The tapered portion tapers to a roundedleading end 208 which, in the example given, has a diameter of 1.0 mm. - The
dilator 203 is secured to thesheath 201 by the dilator handle 206 being releasably secured inclips 219 on thesheath handle 205. With thedilator 203 so secured to thesheath 201, thedilator body portion 202 is slidably received within thesheath body 215 and the dilator taperedportion 204 protrudes beyond thesheath leading end 217. - The
leading end 208 of the taperedportion 204 is sized to have a diameter sufficiently small for theleading end 208 to slip into thelumen 100 of the contractedsize artery 102. Further advancement of the dilator and sheath dilates the vessel. A small portion of the fulldiameter dilator body 202 extends beyond thesheath leading end 217 so the vessel is fully dilated before thesheath body 215 is urged into the vessel. - The contracted
size artery 102 can easily slip over theleading end 208 of thedilator 203. Both the dilator and sheath may be lubricious to ease insertion into the vessel. As a result of such insertion, theartery 102 expands to an expanded size surrounding thesheath body 215. - With the
sheath 201 anddilator 203 fully inserted into theartery 102, thedilator 203 can be removed. Theimplant leading end 22 is then placed in thesheath body 215. Specifically, theimplant leading end 22 is inserted into theguide funnel 207. Theguide funnel 207 directs theimplant leading end 22 into thecylindrical sheath body 215. So inserted, the leadingend 22 of theimplant 10 is inserted into theartery 102 and thesheath body 215 is positioned between theimplant 10 and theartery 102 protecting theartery 102 from trauma. - After placement of the
implant 10, thesheath 201 can be removed. The physician simply pulls onhandle 205. This imparts a force which splits thescore line 219. With thescore line 219 split, the surgeon can pull thesheath body 215 rearwardly out of thevessel 102. The flexible material of thesheath body 215 spreads apart at the bend of theimplant 10 to pass thesplit sheath body 215 over the bend so that thesheath body 215 can be removed without disrupting the position of theartery 102 over the implant's leadingend 22. Instead, any frictional force between theartery 102 and thesheath body 215 will tend to further urge theartery 102 over the leadingend 22. Therefore, theartery 102 remains over the leadingend 22 of theimplant 10 and surroundinggroove 13 so theartery 102 can be fixed to theimplant 10 with sutures 70 (FIG. 2) surroundinggroove 13. - Having disclosed the present invention in a preferred embodiment, it will be appreciated that modifications and equivalents may occur to one of ordinary skill in the art having the benefits of the teachings of the present invention. It is intended that such modifications shall be included within the scope of the claims appended hereto.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/793,318 US6454760B2 (en) | 1999-01-15 | 2001-02-26 | Insertion tool for transmyocardial implant |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/232,272 US6193726B1 (en) | 1999-01-15 | 1999-01-15 | Insertion tool for transmyocardial implant |
US09/793,318 US6454760B2 (en) | 1999-01-15 | 2001-02-26 | Insertion tool for transmyocardial implant |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/232,272 Continuation US6193726B1 (en) | 1999-01-15 | 1999-01-15 | Insertion tool for transmyocardial implant |
Publications (2)
Publication Number | Publication Date |
---|---|
US20010012948A1 true US20010012948A1 (en) | 2001-08-09 |
US6454760B2 US6454760B2 (en) | 2002-09-24 |
Family
ID=22872486
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/232,272 Expired - Fee Related US6193726B1 (en) | 1999-01-15 | 1999-01-15 | Insertion tool for transmyocardial implant |
US09/793,318 Expired - Fee Related US6454760B2 (en) | 1999-01-15 | 2001-02-26 | Insertion tool for transmyocardial implant |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/232,272 Expired - Fee Related US6193726B1 (en) | 1999-01-15 | 1999-01-15 | Insertion tool for transmyocardial implant |
Country Status (1)
Country | Link |
---|---|
US (2) | US6193726B1 (en) |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6582444B2 (en) | 1999-08-04 | 2003-06-24 | Percardia, Inc. | Blood flow conduit delivery system and method of use |
US6605053B1 (en) | 1999-09-10 | 2003-08-12 | Percardia, Inc. | Conduit designs and related methods for optimal flow control |
US6610100B2 (en) | 1998-09-10 | 2003-08-26 | Percardia, Inc. | Designs for left ventricular conduit |
US6641610B2 (en) | 1998-09-10 | 2003-11-04 | Percardia, Inc. | Valve designs for left ventricular conduits |
US6694983B2 (en) | 1998-09-10 | 2004-02-24 | Percardia, Inc. | Delivery methods for left ventricular conduit |
US20100094397A1 (en) * | 2003-07-22 | 2010-04-15 | Medtronic Vascular, Inc. | Method of Implanting a Transmyocardial Stent |
US7704222B2 (en) | 1998-09-10 | 2010-04-27 | Jenavalve Technology, Inc. | Methods and conduits for flowing blood from a heart chamber to a blood vessel |
US9295393B2 (en) | 2012-11-09 | 2016-03-29 | Elwha Llc | Embolism deflector |
US10993805B2 (en) | 2008-02-26 | 2021-05-04 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US11065138B2 (en) | 2016-05-13 | 2021-07-20 | Jenavalve Technology, Inc. | Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system |
US11185405B2 (en) | 2013-08-30 | 2021-11-30 | Jenavalve Technology, Inc. | Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame |
US11197754B2 (en) | 2017-01-27 | 2021-12-14 | Jenavalve Technology, Inc. | Heart valve mimicry |
US11337800B2 (en) | 2015-05-01 | 2022-05-24 | Jenavalve Technology, Inc. | Device and method with reduced pacemaker rate in heart valve replacement |
US11357624B2 (en) | 2007-04-13 | 2022-06-14 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
US11517431B2 (en) | 2005-01-20 | 2022-12-06 | Jenavalve Technology, Inc. | Catheter system for implantation of prosthetic heart valves |
US11564794B2 (en) | 2008-02-26 | 2023-01-31 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US11589981B2 (en) | 2010-05-25 | 2023-02-28 | Jenavalve Technology, Inc. | Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003524444A (en) * | 1998-09-10 | 2003-08-19 | パーカーディア,インコーポレイティド | TMR shunt |
US6193726B1 (en) | 1999-01-15 | 2001-02-27 | Heartstent Corporation | Insertion tool for transmyocardial implant |
US6409697B2 (en) | 1999-05-04 | 2002-06-25 | Heartstent Corporation | Transmyocardial implant with forward flow bias |
US6638237B1 (en) * | 1999-08-04 | 2003-10-28 | Percardia, Inc. | Left ventricular conduits and methods for delivery |
US6253768B1 (en) | 1999-08-04 | 2001-07-03 | Percardia, Inc. | Vascular graft bypass |
US6976990B2 (en) * | 2001-01-25 | 2005-12-20 | Percardia, Inc. | Intravascular ventriculocoronary bypass via a septal passageway |
US20030036698A1 (en) * | 2001-08-16 | 2003-02-20 | Robert Kohler | Interventional diagnostic catheter and a method for using a catheter to access artificial cardiac shunts |
US6808504B2 (en) | 2001-10-04 | 2004-10-26 | Percardia, Inc. | Multi-lumen implant |
US6949118B2 (en) * | 2002-01-16 | 2005-09-27 | Percardia, Inc. | Encased implant and methods |
US7008397B2 (en) * | 2002-02-13 | 2006-03-07 | Percardia, Inc. | Cardiac implant and methods |
US20030216801A1 (en) * | 2002-05-17 | 2003-11-20 | Heartstent Corporation | Transmyocardial implant with natural vessel graft and method |
US20030220661A1 (en) * | 2002-05-21 | 2003-11-27 | Heartstent Corporation | Transmyocardial implant delivery system |
US7326219B2 (en) * | 2002-09-09 | 2008-02-05 | Wilk Patent Development | Device for placing transmyocardial implant |
FR2846520B1 (en) * | 2002-11-06 | 2006-09-29 | Roquette Freres | USE OF MALTODEXTRINS BRANCHED AS BLEACHES OF GRANULATION |
US20040147868A1 (en) * | 2003-01-27 | 2004-07-29 | Earl Bardsley | Myocardial implant with collar |
IES20030531A2 (en) * | 2003-07-17 | 2005-09-21 | Medtronic Vascular Connaught | Methods and devices for placing a fistula device in fluid communication with a target vessel |
US7371251B2 (en) * | 2005-06-02 | 2008-05-13 | Cordis Neurovascular, Inc. | Stretch resistant embolic coil delivery system with mechanical release mechanism |
US20060276825A1 (en) * | 2005-06-02 | 2006-12-07 | Vladimir Mitelberg | Stretch resistant embolic coil delivery system with mechanical release mechanism |
US20080071343A1 (en) * | 2006-09-15 | 2008-03-20 | Kevin John Mayberry | Multi-segmented graft deployment system |
WO2009105699A1 (en) | 2008-02-22 | 2009-08-27 | Endologix, Inc. | Design and method of placement of a graft or graft system |
US8236040B2 (en) * | 2008-04-11 | 2012-08-07 | Endologix, Inc. | Bifurcated graft deployment systems and methods |
EP2293838B1 (en) | 2008-07-01 | 2012-08-08 | Endologix, Inc. | Catheter system |
EP2429452B1 (en) | 2009-04-28 | 2020-01-15 | Endologix, Inc. | Endoluminal prosthesis system |
US9113970B2 (en) | 2010-03-10 | 2015-08-25 | Orthohelix Surgical Designs, Inc. | System for achieving selectable fixation in an orthopedic plate |
EP2635241B1 (en) | 2010-11-02 | 2019-02-20 | Endologix, Inc. | Apparatus for placement of a graft or graft system |
WO2012118901A1 (en) | 2011-03-01 | 2012-09-07 | Endologix, Inc. | Catheter system and methods of using same |
WO2017004265A1 (en) | 2015-06-30 | 2017-01-05 | Endologix, Inc. | Locking assembly for coupling guidewire to delivery system |
US10556094B2 (en) | 2017-03-15 | 2020-02-11 | Radux Devices, LLC | Interventional tool delivery devices, systems and methods |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4401237C2 (en) * | 1994-01-18 | 1997-06-05 | Ruesch Willy Ag | Trocar device |
US5755682A (en) | 1996-08-13 | 1998-05-26 | Heartstent Corporation | Method and apparatus for performing coronary artery bypass surgery |
US5984956A (en) | 1997-10-06 | 1999-11-16 | Heartstent Corporation | Transmyocardial implant |
US6029672A (en) * | 1998-04-20 | 2000-02-29 | Heartstent Corporation | Transmyocardial implant procedure and tools |
US6193726B1 (en) | 1999-01-15 | 2001-02-27 | Heartstent Corporation | Insertion tool for transmyocardial implant |
-
1999
- 1999-01-15 US US09/232,272 patent/US6193726B1/en not_active Expired - Fee Related
-
2001
- 2001-02-26 US US09/793,318 patent/US6454760B2/en not_active Expired - Fee Related
Cited By (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8216174B2 (en) | 1998-09-10 | 2012-07-10 | Jenavalve Technology, Inc. | Methods and conduits for flowing blood from a heart chamber to a blood vessel |
US6610100B2 (en) | 1998-09-10 | 2003-08-26 | Percardia, Inc. | Designs for left ventricular conduit |
US6641610B2 (en) | 1998-09-10 | 2003-11-04 | Percardia, Inc. | Valve designs for left ventricular conduits |
US6694983B2 (en) | 1998-09-10 | 2004-02-24 | Percardia, Inc. | Delivery methods for left ventricular conduit |
US7704222B2 (en) | 1998-09-10 | 2010-04-27 | Jenavalve Technology, Inc. | Methods and conduits for flowing blood from a heart chamber to a blood vessel |
US7736327B2 (en) | 1998-09-10 | 2010-06-15 | Jenavalve Technology, Inc. | Methods and conduits for flowing blood from a heart chamber to a blood vessel |
US8597226B2 (en) | 1998-09-10 | 2013-12-03 | Jenavalve Technology, Inc. | Methods and conduits for flowing blood from a heart chamber to a blood vessel |
US6582444B2 (en) | 1999-08-04 | 2003-06-24 | Percardia, Inc. | Blood flow conduit delivery system and method of use |
US6605053B1 (en) | 1999-09-10 | 2003-08-12 | Percardia, Inc. | Conduit designs and related methods for optimal flow control |
US20100094397A1 (en) * | 2003-07-22 | 2010-04-15 | Medtronic Vascular, Inc. | Method of Implanting a Transmyocardial Stent |
US8156942B2 (en) * | 2003-07-22 | 2012-04-17 | Medtronic Vascular, Inc. | Method of implanting a transmyocardial stent |
US11517431B2 (en) | 2005-01-20 | 2022-12-06 | Jenavalve Technology, Inc. | Catheter system for implantation of prosthetic heart valves |
US11357624B2 (en) | 2007-04-13 | 2022-06-14 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
US10993805B2 (en) | 2008-02-26 | 2021-05-04 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US11154398B2 (en) | 2008-02-26 | 2021-10-26 | JenaValve Technology. Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US11564794B2 (en) | 2008-02-26 | 2023-01-31 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US11589981B2 (en) | 2010-05-25 | 2023-02-28 | Jenavalve Technology, Inc. | Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent |
US9414752B2 (en) | 2012-11-09 | 2016-08-16 | Elwha Llc | Embolism deflector |
US9295393B2 (en) | 2012-11-09 | 2016-03-29 | Elwha Llc | Embolism deflector |
US11185405B2 (en) | 2013-08-30 | 2021-11-30 | Jenavalve Technology, Inc. | Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame |
US11337800B2 (en) | 2015-05-01 | 2022-05-24 | Jenavalve Technology, Inc. | Device and method with reduced pacemaker rate in heart valve replacement |
US11065138B2 (en) | 2016-05-13 | 2021-07-20 | Jenavalve Technology, Inc. | Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system |
US11197754B2 (en) | 2017-01-27 | 2021-12-14 | Jenavalve Technology, Inc. | Heart valve mimicry |
Also Published As
Publication number | Publication date |
---|---|
US6454760B2 (en) | 2002-09-24 |
US6193726B1 (en) | 2001-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6193726B1 (en) | Insertion tool for transmyocardial implant | |
US4574806A (en) | Tunnelling device for peripheral vascular reconstruction | |
US5980503A (en) | Endoscopic cardioplegia infusion cannula and method of use | |
US6237607B1 (en) | Transmyocardial implant procedure | |
US8382784B2 (en) | Vessel cutting devices | |
US5370647A (en) | Tissue and organ extractor | |
AU658932B2 (en) | Endoscopic tissue manipulator | |
EP2170431B1 (en) | Device for establishing supplemental circulatory blood flow | |
US8226670B2 (en) | Apparatus and method for connecting a conduit to a hollow organ | |
US8357190B2 (en) | Laparoscopic vascular access | |
US7309343B2 (en) | Method for cutting tissue | |
US8070675B2 (en) | Penile prosthesis cap and assembly | |
US20040098012A1 (en) | Cannula for receiving surgical instruments | |
AU2003273317A1 (en) | Device for providing thoracoscopic intracardiac access | |
EP2962665B1 (en) | Penile prosthesis cap | |
US20030074057A1 (en) | Method and apparatus for performing an anastamosis | |
US7985176B1 (en) | Method of implanting a penile prosthesis | |
US8206441B2 (en) | Corneal endothelial tissue inserter | |
US20220304725A1 (en) | Apparatus and method for implanting an arteriovenous graft | |
WO2022240660A1 (en) | Directable tunnel device for subcutaneous implantable cardio defibrillator | |
US20110125105A1 (en) | Conduit protector | |
JP2024502267A (en) | Apparatus and method for septal punch and delivery and maneuvering of therapeutic devices | |
JPS6373973A (en) | Marine breast part catheter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: PERCARDIA, INC., NEW HAMPSHIRE Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:HEARTSTENT CORPORATION;REEL/FRAME:014964/0089 Effective date: 20031024 |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
AS | Assignment |
Owner name: HORIZON TECHNOLOGY FUNDING COMPANY LLC, CONNECTICU Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:PERCARDIA, INC.;REEL/FRAME:018375/0912 Effective date: 20060701 |
|
REMI | Maintenance fee reminder mailed | ||
LAPS | Lapse for failure to pay maintenance fees | ||
STCH | Information on status: patent discontinuation |
Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |
|
FP | Expired due to failure to pay maintenance fee |
Effective date: 20100924 |